Catalent, Inc. Reports Third Quarter Fiscal 2024 Results
Catalent, Inc. (CTLT)
Last catalent, inc. earnings: 2/3 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
investor.catalent.com
Company Research
Source: Business Wire
Q3'24 net revenue of $1.07 billion increased 4% as reported, or 3% in constant currency(1), compared to Q3'23.Q3'24 net revenue, excluding COVID-related revenue of ~$120 million in Q3’23 and ~$60 million in Q3’24, increased 11% compared to Q3'23.Q3'24 net loss of $(101) million compared to $(227) million of net loss in Q3'23.Q3'24 Adjusted EBITDA(1) of $163 million increased 55% as reported, or 53% in constant currency, compared to Q3'23.(1) See “Non-GAAP Financial Measures” below and the GAAP to non-GAAP reconciliation provided later in this release. SOMERSET, N.J.--(BUSINESS WIRE)--Catalent, Inc. (NYSE: CTLT) (“Catalent”), the leader in enabling the development and supply of better treatments for patients worldwide, today announced financial results for the third quarter of fiscal 2024, which ended March 31, 2024.“I am pleased to report that in the fiscal third quarter Catalent returned to growth, including double-digit non-COVID year-on-year revenue growth. We also continued our
Show less
Read more
Impact Snapshot
Event Time:
CTLT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CTLT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CTLT alerts
High impacting Catalent, Inc. news events
Weekly update
A roundup of the hottest topics
CTLT
News
- Pharmaceutical Contract Packaging Market Size Expected to Reach USD 36.11 Bn by 2032 [Yahoo! Finance]Yahoo! Finance
- Cell and Gene Therapy Manufacturing Research Report 2024 [Yahoo! Finance]Yahoo! Finance
- Drug Discovery Outsourcing Market size is set to grow by USD 1.79 bn from 2024-2028, robust demand for biosimilars to boost the market growth, Technavio [Yahoo! Finance]Yahoo! Finance
- $19.81 Billion Large Molecule Drug Substance Contract Development and Manufacturing Organization (CDMO) Market Analysis - Global Industry Size, Share, Trends, Opportunity & Forecast, 2019-2029F [Yahoo! Finance]Yahoo! Finance
- Small Molecule Innovator API CDMO Research Report 2024: Global Market to Reach $47.14 Billion by 2030 driven by Increasing Demand for Small Molecule Drugs, and Surge in Clinical Trials [Yahoo! Finance]Yahoo! Finance
CTLT
Earnings
- 2/9/24 - Miss
CTLT
Sec Filings
- 5/16/24 - Form DEFA14A
- 5/16/24 - Form 8-K
- 5/13/24 - Form 144
- CTLT's page on the SEC website